Tirzepatide not recommend for type 2 diabetes treatment
National Institute of Health and Care Excellence (NICE) has not recommended 'Tirzepatide', also known as Mounjaro, developed by Eli Lilly, in its draft guidance...
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc